Devices: Investments

Medical Device Investors on the State of the Market

Moderator: Geoff Pardo, MBA, Partner, Gilde Healthcare
Amy Belt Raimundo, MBA, Managing Director, Kaiser Permanente Ventures
James Eadie, MD, Partner, Santé Ventures
Bryan Grulke, MBA, Partner, Volcano Capital
Renee Yao, Global Healthcare AI Startups Lead, NVIDIA

Intelligent, software-driven, data-gathering, real-time monitoring, robotic, human interface capability is on the verge of changing the investment equation within the healthcare domain. Next-generation medical devices range from nano–, micro–, and head-of-a-pin miniature to large robotic machines that are fully integrated into the network and sophisticated enough to perform human-guided operations. Learn what top investors are seeing in the medtech space, and the implications for early-stage start-ups looking to lead the charge via AI-enabled technology in medical device applications.

Panelist Bios

Amy Belt Raimundo, MBA, Managing Director, Kaiser Permanente Ventures
Amy Belt Raimundo joined Kaiser Permanente Ventures as managing director. Amy brings over 20 years of experience in healthcare investing, start-up and corporate operations, and hospital system consulting. Immediately prior to joining Kaiser, Amy was the Chief Business Officer of digital health start-up Evidation Health founded by GE Ventures and Stanford Healthcare where she led all commercial and business development activities. Previously, Amy spent close to a decade in venture capital-focused on healthcare technology as a Vice President at Covidien Ventures and Advanced Technology Ventures (ATV). She led investments in Medina Medial (acquired by Medtronic) and Nevro Corporation (NYSE: NVRO) among others. Earlier in her career, Amy held operating roles at Guidant Corporation (acquired by Abbott Vascular) including leading the international launch of the Xience drug-eluting stent and managing product lines across the US, Europe, and Asia. She began her career as a management consultant for APM/CSC Healthcare, optimizing operations, and clinical guidelines for major hospital systems. Amy is a Kauffman Venture Fellow as well as founder and president of MedtechWomen. She holds a BA in Economics from Yale University and an MBA from the University of California at Berkeley.

James Eadie, MD, Partner, Santé Ventures
James joined Santé Ventures in 2009 and is an emergency medicine physician. Prior to joining Santé, James served in the Air Force and was Vice-Chair of Emergency Medicine at Wilford Hall Medical Center, an academic level-one trauma center. He completed two tours in Iraq as a Critical Care Transport Team Chief and Emergency Department Commander, before separating honorably as a Major in 2008. James is an Oversight Committee member for the University of Michigan’s Michigan Translational Research & Commercialization program, an early-stage granting body for life science companies. He is also a Mentor in the Coulter Program at Michigan and a Board Member of the Michigan Center for Integrative Research in Critical Care. James is board-certified in emergency medicine and completed his residency at Massachusetts General Hospital and Brigham and Women’s Hospital. He earned his MD from the Harvard–MIT Program in Health Sciences and Technology (HST), his MBA from the University of Texas McCombs School of Business and his BS in bioengineering, Summa Cum Laude, from the University of Michigan.

Bryan Grulke, MBA, Partner, Volcano Capital
Bryan Grulke is a Partner at Volcano Capital, an early-stage healthcare venture capital firm with offices in New York City and San Francisco. Volcano Capital focuses on the medical device sector and has made 15+ investments to date. Prior to joining Volcano Capital, Mr. Grulke worked as a strategy consultant at Bain & Company and in the corporate strategy group at Philips International. Mr. Grulke graduated from Harvard Business School and Duke University, summa cum laude with a BS degree in Economics.

Geoff Pardo, Partner, Gilde Healthcare (Moderator)
Geoff Pardo joined Gilde Healthcare in 2011 as a Partner working out of the office in Boston/Cambridge, MA and is focusing on Gilde’s investments in North America. He led the investments in Ablative Solutions, Inari Medical (NASDAQ: NARI), Axonics Modulation Technologies (NASDAQ: AXNX), CVRx, InovaLabs (acquired by ResMed), BionX (acquired by Ottobock), Vapotherm (NYSE: VAPO), Vesper Medical and Eargo. He represents Gilde as a member of the board of directors for each company. Previously, he was a Partner at Spray Venture Partners where he led investments into Interlace Medical (sold to Hologic), Solace Therapeutics, TearScience (sold to J&J) and Cascade Ophthalmics. He served on the board of Solace, TearScience and Cascade, and was actively involved in Interlace and Conventus Orthopedics. Geoff also served as President & CEO of Facet Solutions, a spinal implant company focused on treating lumbar spinal stenosis until the company was sold to Globus Medical in 2011. He has also worked at Cardinal Partners as an Associate leading their investing activity in the medical device sector. Geoff began his career in medical devices as a product manager with Synthes USA. He has a BA with honors in History from Brown University and an MBA from the Wharton School of Business. He is a US citizen based in Gilde Healthcare’s Cambridge, MA office.

Renee Yao, Global Healthcare AI Startups Lead, NVIDIA
Renee Yao leads global healthcare AI startups at NVIDIA, managing 1000+ Inception healthcare startups in digital health, medical instruments, medical imaging, genomics, and drug discovery segments. NVIDIA Inception provides AI startups go-to-market support, expertise, and technology. Previously she worked as a senior product manager on AI Systems at NVIDIA, focusing on developing reference architecture for at-scale deployment, building ecosystems partnerships, and accelerating solution bundling. She graduated from Haas School of Business at the UC Berkeley, with a focus in economics and IT. In her free time, she enjoys competitive ballroom dancing and reading.